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https://doi.org/10.1016/j.stemcr.2020.03.018SUMMARYHuntington disease (HD) is an inherited late-onset neurological disorder characterized by progressive neuronal loss and disruption of
cortical and basal ganglia circuits. Cell replacement using human embryonic stem cells may offer the opportunity to repair the damaged
circuits and significantly ameliorate disease conditions. Here, we showed that in-vitro-differentiated human striatal progenitors undergo
maturation and integrate into host circuits upon intra-striatal transplantation in a rat model of HD. By combining graft-specific immu-
nohistochemistry, rabies virus-mediated synaptic tracing, and ex vivo electrophysiology, we showed that grafts can extend projections to
the appropriate target structures, including the globus pallidus, the subthalamic nucleus, and the substantia nigra, and receive synaptic
contact from both host and graft cells with 6.6 ± 1.6 inputs cell per transplanted neuron. We have also shown that transplants elicited a
significant improvement in sensory-motor tasks up to 2 months post-transplant further supporting the therapeutic potential of this
approach.INTRODUCTION
Huntington disease (HD) is a monogenetic dominant
neurodegenerative condition still orphan of a disease-
modifying therapy (Caron et al., 2018). Disease-driving
mutations at the HTT locus result in expansion of the
CAG trinucleotide repeat tract residing at the 50 end of
HTT exon 1. Expansions larger than 36 repeats trigger
neuronal cell loss that preferentially affects striatal projec-
tion neurons (medium spiny neurons [MSNs]) but eventu-
ally spread to cortical and subcortical regions, ultimately
leading to a progressive and irreversible deterioration of
cognitive and motor faculties over a period of 20–30 years
(Vonsattel et al., 2008).
Recent technological advancements have promoted the
emerging of a number of promising strategies aimed at
the attenuation of mutant HTT (mutHTT) expression in
an allele-specific or non-specific manner (Tabrizi et al.,
2019a; Zeitler et al., 2019). These approaches hold substan-
tial hope for mitigating or delaying disease progression
(Tabrizi et al., 2019b); however, the loss of neurons occur-St
This is an open access article under the Cring before manifestation of symptoms may reduce the
impact of mutHTT-lowering strategies, therefore, comple-
mentary therapies must be pursued to secure a successful
action against HD.
Regenerative medicine aims to develop strategies that
can ultimately lead to functional restoration of the affected
tissue. Because of the initial selective vulnerability for stria-
tal neurons in HD, this neurodegenerative condition is
particularly suited for cell replacement approaches aimed
at mitigating MSN loss. Some attempts at using donor cells
derived from whole ganglionic eminence of the human
fetal brain were pursued (Lelos et al., 2016; Pundt et al.,
1996) but with variable results and limited applicability
to the clinical context. Therefore, researchers have since
looked into an expandable and more reliable cell source
for transplantation. MSN-committed progenitors obtained
from in-vitro-differentiated human pluripotent stem cells
represent a key source in cell replacement approaches.
Accordingly, a number of protocols have been developed
to capture committed MSN progenitors able to survive
in vivo and restore target tissue activity (Adil et al., 2018;em Cell Reports j Vol. 14 j 1–16 j May 12, 2020 j ª 2020 The Author(s). 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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All these studies, however, have generatedMSN-like neu-
rons in vitrowith different degrees of success and efficiency
but none has identified the donor cells by assessing the co-
expression of the MSN-unique marker combination
DARPP32/CTIP2/GABA, leaving unverified the specific
neuronal characteristics of the obtained cell product.More-
over, some of these procedures rely on difficult co-culture
system (Aubry et al., 2008) or complex manipulation that
includes generation of embryoid bodies (Ma et al., 2012)
or sophisticated hydrogel-based 3D systems (Adil et al.,
2018); they lack functional validation in vivo (Nicoleau
et al., 2013) or lacked functional recovery after transplanta-
tion (Arber et al., 2015).
The long-term efficacy of this approach requires lasting
and extensive integration of the graft-to-host circuits and
the graft projections must be able to reach striatal target re-
gions and make synaptic contact with the host cells to
restore the compromised networks (Wictorin, 1992). These
aspects can be investigated with greater granularity in the
larger rat brain with respect to the smaller distant rodent
cousin.
Here, we present evidence of therapeutic efficacy of a cell
replacement approach that uses human embryonic stem
cell (ESC)-derivedMSNprogenitors implanted into a chem-
ically lesioned rat model of HD. Cells differentiated accord-
ing to a modified protocol by Carri et al. (2013) and others
(Conforti et al., 2018; Faedo et al., 2017) were systemati-
cally and longitudinally qualified during the entire
in vitro procedure. Implanted cells showed high rate of graft
survival in the absence of uncontrolled overgrowth as
judged by positron emission tomography (PET)/magnetic
resonance imaging (MRI) longitudinal monitoring and
IHC. Importantly, a proportion of donor cells underwent
maturation toward identity of MSNs as judged by
DARPP32, CTIP2, and GABA expression. They were also
able to integrate into the host tissue by reaching striatal
target regions and by receiving synaptic connections as re-
vealed by rabies virus (RV)-based synaptic tracing and
confirmed by ex vivo patch-clamp analysis. Moreover,
short-term behavioral studies using different tasks demon-
strated functional recovery in lesion-dependent sensori-
motor responses.
Results
Human Striatal Progenitor-Derived Grafts Mature in the
Lesioned Rat Striatum and Consist of Medium Spiny Projection
Neurons 2 Months after Surgery
With the aim of exploring the potential efficacy of an
hESC-based cell therapy for HD in a preclinical setup, we
have exposed the hESC line H9 to a striatal differentiation
protocol modified from (Carri et al. 2013) (Figure S1A). Sys-2 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020tematic in vitro cell phenotyping by immunocytochemistry
and high-content qPCR revealed a temporal expression
pattern that recapitulates trajectories of human ventral
telencephalon development (Figures 1A–1D). The cells,
starting from a pluripotent state (Figure S1B), show neuro-
ectodermal fate acquisition with 40% ± 13.7% becoming
PAX6-positive by 15 days in vitro (DIV) (Figure 1B). Early
neurons with ventral telencephalic phenotype increased
over time, reaching 30.36% ± 11.28% for CTIP2-expressing
cells by 50 DIV, with 13.92% ± 1.91% of total cells being
CTIP2/DARPP32 double positive and 6.3% ± 0.8% CTIP2/
DARPP32/GABA triple-positive (Figures 1A and 1C).
Contamination by neurons with cortical identity was
only marginal (Figure S1C). High-content qPCR analysis
on 49 different markers confirmed subpallial fate acquisi-
tion with subpallial- and LGE-specific markers increasing
over time until the end of differentiation. Conversely, the
expression of pallial markers picked during early differenti-
ation then declined at 50 DIV (Figure 1D; Table S3).
To test the in vivo survival and maturation, we first ad-
dressed best in vitro maturation time for optimal graft sur-
vival 2 weeks after transplantation (data not shown) and
accordingly we have selected 20 DIV cells to be grafted
unilaterally in the striatum of quinolinic acid (QA)-
lesioned athymic adult rats. The transplanted animals
were followed up for 2 months and then sacrificed for
neuroanatomical analyses. We found robust cell survival
with 8,905.23 ± 643.9 human nuclei (HuNu)-positive cells
per mm2 that occupied a volume of about 6.53 ± 0.6 mm3
per animal (n = 6).
We then analyzed the expression ofmarkers of immature
and mature striatal neurons in HuNu+ grafted cells (Fig-
ure 2). Of note, the striatal marker CTIP2 was expressed
in about half of all the grafted cells (45.3% ± 1.94%, Figures
2B and 2E), 6.14% ± 0.6% among the grafted cells were pos-
itive for the striatal determinants EBF1 (Figures 2A and 2E),
while cells coexpressing themoremature marker DARPP32
together with CTIP2, typical of MSNs, were 2.80% ± 0.33%
(Figures 2B and 2E), with almost all DARPP32-expressing
cells coexpressing the striatal determinant CTIP2. In a
few instances, grafted cells differentiated along the inter-
neuronal lineage and expressed interneuronal markers,
such as Calbindin (CB) (1.83% ± 0.14%) or Calretinin
(CR) (2.61% ± 0.42%) (Figures 2C and 2E). A diffuse positiv-
ity for the GABA antigen was visible in the graft area, with
28.2% ± 0.8% of the population displaying a strong stain-
ing suggestive of an inhibitory identity (Figures 2D and
2E). A minor proportion of human cells instead progressed
along the astroglial lineage and showed glial fibrillary
acidic protein (GFAP) positivity (2.14% ± 0.23%; Figure 2E).
Moreover, less than 1% of the grafted elements differenti-
ated along the dopaminergic lineage and expressed Tyro-




Figure 1. Cell Phenotyping during In Vitro Differentiation Shows Maturation toward the Expected Striatal Cell Lineage
(A) Representative images showing cell marker expression at different time points during in vitro differentiation. Arrowheads indicate
triple-positive cells. Scale bar, 25 mm; bottom right inset shows corresponding DAPI staining. Scale bar, 25 mm.
(B) Quantification of relative frequencies of PAX6-, Ki67-, p27-, CTIP2-, EBF1-, ISLET1-, GSX2-, and ASCL1-expressing cells over the total
population as defined by DAPI staining during in vitro differentiation (mean ± SEM; n = 3 independent experiments, Table S3).
(C) Quantification of cells at the end of differentiation (50 DIV) showing expression of the marker CTIP2, DARPP32, or combination of
markers DARPP32/CTIP2, DARPP32/CTIP2/GABA (n = 2 independent experiments), and EBF1/CTIP2 compared with the total population of
cells (mean ± SEM; n = 3 independent experiments).
(D) Gene expression of selected region-specific markers at different times during the entire differentiation protocol. Color scale shows log2
fold change compared with mean expression at 0 DIV for each subset of genes (mean, n = 3 independent experiments; see also Figure S1
and Table S3).
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was still present (67.80% ± 4.5%of HuNu+ cells), indicating
incomplete maturation at this time. Nevertheless, we de-
tected relatively few proliferating cells expressing Ki67
(8.69% ± 1.1% of all HuNu+ cells) (Figure 2E).
We also evaluated the occurrence of astrogliosis and mi-
croglia activation within the grafts in comparison with
either QA-lesioned striata that did not receive the trans-
planted cells (sham) or to the contralateral unlesioned
side (Figure S2). GFAP expression was strongly upregulated
by the QA lesion but the graft did not appear to affect GFAP
levels (Figures S2A and S2B). Moreover, in the striatum of
sham-lesioned animals, microglial cells (IBA1-positive) dis-
played an overtly activated morphology (Figure S2C), and
increased in density, indicating ongoing neuroinflamma-
tion. Conversely, upon transplantation, a decrease in mi-
croglia activation was observed, although IBA1 levels did
not reach the values of the intact unlesioned side
(Figure S2D).
Together, these findings demonstrated that the selected
striatal progenitors effectively survived the transplanta-
tion, progressed in their maturation along the MSN line-
age, and partly attenuated ongoing inflammation.Transplanted Cells Emit Axons and Project toward
Striatal Targets
Axonal outgrowth toward appropriate target regions is
essential for the correct reconstitution of the lost circuits
and the achievement of long-term therapeutic benefit. To
study the dynamics of graft-derived neurite extension, we
examined the selective expression of human Neural cell
adhesion molecule (hNCAM) in serial sections of grafted
rats along the entire rostro-caudal extension of the fore-
brain and down to the substantia nigra (SN). We distin-
guished the core of the graft by hNCAM labeling of human
neuronal cell bodies, and estimated the areas covered by
hNCAM+ fibers as well as the density of hNCAM positivity
in the brain section at 1 and 2 months post-transplant
(MPT) (Figure 3).
A dense anti-hNCAM staining was observed in the
caudate-putamen region both at 1 and 2MPT, which corre-
sponded to the main graft location (Figure 3A). When we
examined the pattern of hNCAM+ fibers outside the core
of the transplant, we observed a progressive expansion of
hNCAM+ areas within the MSN ipsilateral target regions,
such as the globus pallidus (GP) (Figure 3B) and SN pars re-
ticulata (SNpr) (Figure 3D). hNCAM+fibers also extended toStem Cell Reports j Vol. 14 j 1–16 j May 12, 2020 3
Figure 2. Maturation of Grafted Cells In Vivo Demonstrated Successful Acquisition of Striatal Fate
(A) Representative graft images showing a fraction of striatal progenitors positive for the NESTIN antigen (NESTIN, white) and EBF1 (red).
Insets a and a’ show a higher magnification of NESTIN+/EBF1+ cells.
(B) hESC-derived striatal progenitors positive for HuNu mature into MSN neurons expressing CTIP2 and DARPP32. Lateral panels show
colocalization through digital rendering. Yellow arrowheads indicate human cells (HuNu+) double-labeled with CTIP2 and DARPP32.
(C) Detail of graft interneurons (green) expressing calbindin (CB) (red).
(D) A diffuse immunopositivity for GABA signal is present in the graft core, with some cells highly marked (white arrowheads).
(E) The graph shows the proportion of cell-type-specific marker expression 2 MPT in HuNu+ neurons. Data are represented as mean ± SEM;
n = 6 animals. Scale bars, 20 mm for (A), (B), and (D) and the inset of (C), 50 mm for the main panel of (C).
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and the subthalamic nucleus (STN) (Figure 3C). The quan-
tification of the area covered by hNCAM+ fibers showed
that, at 1 MPT, rare axonal fibers had reached the SN (Fig-
ure 3D), while they were more abundant in the GP and
STN (Figures 3B and 3C). However, by 2 MPT, increased
hNCAM projections were observed extending along the
antero-posterior axis with more fibers in the GP and reach-
ing as far caudal as the SN (Figure 3E).
The increase in fiber extension from 1 to 2 MPT was
confirmed by the quantification of the density of hNCAM+
fibers (Figure 3F). In particular, a significant increase in
hNCAM+ staining intensity was observed in the VM
thalamic region and the SNpr at 2 MPT, compared with
the earlier time point, confirming that grafted cells progres-
sively extend neurites that reach target regions anatomi-
cally appropriate for striatal MSNs (Figure 3F). Fewer
hNCAM-positive fibers were detected to grow toward
rostral and dorsal regions. These fibers were found in the
ipsilateral (few) and contralateral (rarely) corpus callosum,
from where they occasionally reached the lower levels of
the motor cortex or the septum (Figure S3). We cannot4 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020exclude that they may have been originated by cells occa-
sionally seeded along the injection track.
Overall, these data indicate that processes from the im-
planted human striatal progenitors expand in the lesioned
striatum and project to striatal target regions in a rat model
of HD.
Monosynaptic Tracing Reveals the Formation of Early
Host-to-Graft Connectivity
Monosynaptic tracing allows for unambiguous identifica-
tion of first-order inputs onto a defined population of starter
neurons, by taking advantage of the selective retrograde
transsynaptic spread of RV. Before grafting, cells were trans-
duced with a lentivirus expressing the rabies helper
construct under control of the human synapsin promoter.
The tracing construct includes histone-tagged GFP (for un-
ambiguous identification of starter cells); TVA receptor
(required for selective primary infection with EnvA-pseudo-
typed glycoprotein-deleted rabies virus [DGRV]); and rabies
glycoprotein (required for transsynaptic spread of DGRV).
One week before sacrifice, transplanted rats received an
intra-graft injection of an DGRV carrying an mCherry
(legend continued on next page)
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cells belonging to the graft (Grealish et al., 2015).
At both 1 and 2 MPT we found grafted cells identified by
nuclear GFP and/or by mCherry as for cells infected by
DGRV. A fraction of the latter cells corresponded to GFP+
starter cells, while those remainingwere first-order afferents,
where the DGRV had spread transsynaptically (traced cells,
mCherry+/GFP) (Figures 4A–4D). mCherry+ neurons were
localized within the striatum in all examined animals and
formed nets with the transplanted cells (Figure 4A, insets
a, a’; Figure 4B, insets b, b’). Two months after graft, both
the starter and the traced elements were significantly
increased within the whole population compared with 1
MPT (Figures 4C and4E). Interestingly, traced cells increased
with time together with a significant increase of the connec-
tivity index (computed as percentage of traced cells over
starter cells; 1.5 ± 0.1 at 1 MPT and 6.6 ± 1.6 at 2 MPT; Wil-
coxon-Mann-Whitney test, 1 versus 2 MPT, p < 0.05; n = 4).
Starter neurons were connected with both cells from the
graft (HuNu+) and cells from the host (HuNu) (Figures 4C–
4F, S4B, and S4E), showing the initial formation of local
synapses and a relevant degree of integration into pre-exist-
ing circuits (Figures 4C and 4F). Among traced cells
(mCherry+/GFP), we found that graft inputs (HuNu+)
were predominant both at 1 and 2MPT (Figure 4F), suggest-
ing that the increase of traced neurons we observed at 2
MPT (Figure 4E) was mainly due to grafted neurons being
integrated in newly established intra-transplant networks.
We then characterized the phenotype of the starter and
traced cells by analyzing marker expression (Figure S4),
and found that a relevant number of mCherry+ cells were
marked by CTIP2, while a small proportion showed expres-
sion of DARPP32––confirming that a fraction of grafted
neurons is further progressing in the MSN lineage––and
of interneuronmarkers (Figure S4A), whilemore frequently
revealing an interneuron identity (Figures 4G and S4D).
Over time, a few DARPP32+ neurons also appeared among
traced host cells, further supporting progressive integration
(Figure 4G). These findings indicate that grafted cells areFigure 3. Axonal Outgrowth from Intra-striatal Grafts of hESC-D
Regions
Neurites emitted by hESC-derived striatal progenitors were visualized
rat coronal sections at 1 and 2 MPT.
(A–D) (A) hNCAM fibers increase is observed between 1 and 2 MPT in th
host brain. For each area, lower panels represent higher-magnificatio
(E) Area innervated by hNCAM+ fibers at the antero-posterior levels sh
structures from 1 to 2 MPT (n = 4 animals per group; two-way ANOVA,
(F) Quantification of hNCAM+ fiber density in the striatal target regio
animals per group; two-way ANOVA, Bonferroni multiple comparison te
putamen; GP, globus pallidus; SNpr, substantia nigra pars reticulata; T
thalamus; STN, diencephalic subthalamic nucleus. Data are represented
(C), and (D); 100 mm for the lower panels (see also Figure S3).
6 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020synaptically integrated and form networks within the graft
and with the host circuits.
In Vivo Imaging Suggests Graft-Mediated Reduction of QA
Inflammatory Response and No Formation of Teratomas
We decided to monitor the transplants in live animals us-
ing clinically relevant MRI and PET imaging techniques.
Microglia activation/macrophage infiltration was imaged
in QA-lesioned animals using PETand the translocator pro-
tein (TSPO) radiopharmaceutical [18F]VC701, at 1 week
(WPT), 2 MPT, or after sham surgery. At early time point
(1 WPT) QA induced a significant increase of [18F]VC701
uptake on lesioned striatum compared with the healthy
contralateral one, in both sham and transplanted animals
(Figure 5A). Conversely, at 2 MPT a significant increase of
[18F]VC701 uptake in the lesioned striatum was observed
only in the sham group (Figure 5B). This result is consistent
with that observed by IBA1-staining quantification (Fig-
ure S2A) and suggests a role for the grafts in reducing QA-
triggered neuroinflammation.
Further analyses of D2/D3 dopamine receptor availability
2 MPT using [11C]RAC as radiopharmaceutical agent did
not show any change in D2/D3-expressing cells in the
transplanted striatum compared with sham controls (Fig-
ure 5C). To verify if cell transplantation was able to reduce
tissue damage induced by QA administration, rats under-
went T1-Gd and T2-weighted MRI studies. Gadolinium
enhancement was reduced in sham-operated rats and ab-
sent in the grafted regions of transplanted animals (Fig-
ure S5C and S5D). This suggests a reduction in resident tis-
sue inflammation promoted by the graft and absence of
neoplastic transformation or teratoma formation. Finally,
sham-operated but not transplanted animals showed en-
largements of ventricles in proximity of the QA-lesioned
sides, suggestive of a cell loss compensation mediated by
the graft (Figures S5A and S5B).
Patch-Clamp Recording of Transplanted Cells Reveal Action
Potentials and Excitatory Synaptic Inputs
To investigate whether the transplanted neurons in the
grafts were functionally active and integrated into the hosterived Striatal Progenitors Shows Targeting of Striatal Target
by hNCAM staining and mapped over a schematic representation of
e GP (B), in the VM Th, and in the STN (C), and in the SNpr (D) of the
n insets.
ows the outgrowth and progressive innervation of host brain target
Bonferroni multiple comparison test: GP, p < 0.01; SNpr, p < 0.05).
ns confirms progressive innervation as far caudal as the SN (n = 4
st: VM, p < 0.05; SNpr, p < 0.01). CC, corpus callosum; CPu, caudate-
RPL, transplant; MPT, months post-transplant; VM Th, ventromedial
as mean ± SEM. Scale bars, 500 mm for the upper panels in (A), (B),
Figure 4. Host-to-Graft Connectivity of hESC-Derived Neurons is Early Established by Forming Synaptic Connections Preferentially
with Interneurons
Schematic illustration of the antero-posterior distribution of mCherry-positive first-order inputs onto grafted cells in a representative
brain at 1 (A) or at 2 (B) MPT. Confocal tile-scan of the entire lesioned hemisphere is presented. The area occupied by the graft is
highlighted by dotted line. a, a0 and b, b0 show portions of the graft at higher magnification, in which viral-labeled mCherry-positive
starter (GFP+) and traced (GFP) cells are observed.
(legend continued on next page)
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merged coronal slices, including GFP-labeled grafted neu-
rons. Grafted cells developed a complex dendritic arboriza-
tion, as observed in cells after labeling with biocytin
injection into the cell through the patch pipette during re-
cordings (Figure 6A). Passive membrane properties, an indi-
rect proof of the degree of differentiation, showed that the
mean average resting membrane potential of transplanted
cells was 55 ± 3 mV, the input resistance was 1801 ± 253
MU, and the membrane capacitance was 41 ± 5 pF (n = 26
cells). A distinctive feature of mature neurons is their ability
to generate action potentials. Because spike generation is
strictly correlated with the expression and activation of
voltage-gated TTX-sensitive Na+ and delayed-rectifier K+
channels, we analyzed ionic currents elicited by depolariz-
ing steps during whole-cell voltage clamp. In Figures 6B
and 6C, a family of Na+ and K+ currents and action potential
firing recorded from a sample of grafted cells are shown,
respectively. Overall, in 4% of the recorded cells the ampli-
tude of the peak Na+ current was negligible, 54% of them
showed a value smaller than 1,000 pA (mean 391 ±
58 pA)––an arbitrary threshold chosen to define a stem
cell-derived mature neuron––whereas the remaining 42%
displayed a peak amplitude greater than 1,000 pA (mean
2,655± 487 pA) (Figure 6D). Accordingly, in current-clamp
mode following supra-threshold stimulation we found that
a small fraction of the recordedneuronswas able to elicit sin-
gle (16%) or repetitive (8%) action potentials, whereas the
remaining cells showed abortive (36%) or non-regenerative
events (40%) (Figure 6E).
The mean peak of Na+ current density, calculated on all
tested cells at the peak value of the I/V relationship, was
28.5 ± 5.3 pA/pF (Figure 6F). These data suggest that a
portion of grafted cells displayed functional mature
neuronal features, i.e., sizable voltage-gatedNa+ andK+ cur-
rents and the ability to generate action potentials.
Similarly, the voltage-gated K+ current density measured
at +30 mV at the steady state gave a value of 988 ± 118 pA/(C) Confocal images representing the distribution of rabies-labeled ce
gray-scale image where starter cells are labeled in yellow, graft trace
(D and DI) Representative image showing examples of a starter cell (d
the host (div) with related magnification and re-slice.
(E) Quantification of graft starter and traced cells showing that both ce
0.05; two-way ANOVA, Bonferroni’s multiple comparison test). Data ar
animal.
(F) Quantification of graft or host connections to starter neurons at 1
Bonferroni’s multiple comparison test). Stars inside the bars indicate
(G) Expression of striatal (CTIP2, DARPP32) and interneuron markers (C
(HuNu) cells, 1 and 2 MPT (***p < 0.001, **p < 0.01, *p < 0.05;
represented as mean ± SEM; n = 4 animals per group.
Scale bars, 1 mm for tile-scan images (A and B); 50 mm for insets a, a0 an
insets. See also Figure S4.
8 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020pF (n = 26 cells). Interestingly, 47% of those cells displayed
also a fast inactivating outward current component sug-
gesting the activation of an A-type K+ current (Figure 6G).
To explore whether grafted neurons receive functional
synaptic inputs (host-to-graft or/and graft-to-graft connec-
tions), we recorded spontaneous postsynaptic potentials
(sPSPs) at 70mV. Nine recorded neurons out of 25 dis-
played excitatory sPSPs with an average amplitude of 1.3
± 0.5 mV (Figure 6H). This result suggests that, at 2 MPT,
a subpopulation of grafted neurons begins to show signs
of functional integration.
Behavioral Assessment of Transplanted QA-Lesioned Rats
Shows Improvement in Sensorimotor Responses
To assess graft-dependent functional recovery, we sub-
jected the transplanted animals to a set of striatum-depen-
dent behavioral tests, including both sensorimotor reflex
responses and more complex motor activities. QA lesion
clearly worsened the performance of the limb contralateral
to the damaged striatum in vibrissae-evoked hand placing
(VHPT) and adjusting step test (AST), but had a less-pro-
nounced effect on the general motor behavior (rotarod)
in both grafted and non-grafted rats, compared with base-
line (Figure 7). In particular, the worsening caused by QA
excitotoxicity had a comparable effect in both sham and
transplanted rats, and no differences between groups
were observed in all tests when rats were examined the
day before grafting (7 days after lesion).
In theVHPT, nodifferenceswere observed before and after
lesion or between sham and grafted rats in the ipsilesional
side performance (Figure S6A). On the contralateral side, sta-
tistically significant differences were observed between
sham and transplanted rats with improved performance in
the grafted animals at 1 MPT (Figure 7A). Consistently, at
2 MPT, the performance of grafted rats on the affected fore-
limb showed a significant improvement to about 190% rela-
tive to their postlesion time point (p < 0.0001; Figure 7A).
In the AST, no differences were detected between
groups in the forward- or backward-adjusting stepsll populations. On the right, mCherry positivity is converted into a
d cells in light blue, and host traced cells in red.
II), and of mCherry+ first afferents belonging to the graft (dIII) or to
ll types increase over time (n = 4 animals per group; **p < 0.01, *p <
e represented as the average number of mCherry+ cells per slice, per
and 2 MPT (n = 4 animals per group; ***p < 0.001; two-way ANOVA,
comparison between HuNu+ and HuNu traced cells.
R, CB) in labeled mCherry+ inputs, from either graft (HuNu+) or host
two-way ANOVA, Bonferroni multiple comparison test). Data are
d b, b0, and for (C); 20 mm for (D) and (DI); 10 mm in dII, dIII, and dIV
Figure 5. Longitudinal PET Imaging of inflammation and Dopamine D2/D3 Receptor Availability
(A and B) MRI-PET images and PET quantification of 18F-VC701 tracer uptake 1 WPT, measuring microglial activation in striatal region in
both hemispheres (unlesioned and lesioned + transplant) 1 WPT (A) and 2 MPT (B); n = 4 animals per group (*p < 0.05, **p < 0.01; paired
Student’s t test); PET images are represented in a ‘‘ten-steps’’ color scale. White arrowheads indicate tracer uptake in the lesioned
hemisphere.
(C) MRI-PET images and PET quantification of the [11C]Raclopride tracer uptake 2 MPT measuring D2/D3 receptor availability on the striatal
region in both hemispheres, n = 3 animals per group (*p < 0.05; paired Student’s t test). Data are expressed as percentage of injected dose
per volume (mL), mean ± SD.
See also Figure S5.
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rimotor Deficit in a Rat Model of Huntington Disease, Stem Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.03.018made using the ipsilateral paw (Figure S6B), while the
analysis of the contralateral forelimb revealed a general
significant improvement in grafted animals, compared
with lesioned only animals, at 1 and 2 MPT (Figure 7B).At 1 and 2 MPT, analyses of the postgraft performance re-
vealed that the affected forelimbs improved to 170% and
130% of the postlesion baseline, respectively (p < 0.0001;
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Figure 6. Transplanted Neurons Generated Action Potentials and Received Excitatory Synaptic Inputs
(A) Biocytin-labeled patched cell showing complex arborization (arrowhead). Scale bar, 50 mm.
(B) Family of sodium (inward) and potassium (outward) currents elicited by voltage steps from a holding potential of 70 mV.
(C) Sample trace elicited from the same neuron as in (B) showing repetitive firing during stimulation with a supra-threshold depolarizing
current step.
(legend continued on next page)
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mances on the rotarod between grafted and sham rats,
which showed a similar decrease in the latency to fall after
lesion (Figure 7C). We also explored the possibility that
transplanted cells could provide trophic support to resident
MSNs that survived the QA lesion. To this aim, we quanti-
fied the density of CTIP2- andDARPP32-expressing rat cells
surrounding the lesion site at 2 MPT and found no differ-
ence between sham and transplanted animals (Figure S7).
Overall, these data show that hESC-derived neuronal
grafts improved sensorimotor reflex responses associated
with striatal circuits up to 2 MPT, but failed to rescue
more complex motor deficits at these early time points.
DISCUSSION
In this study, we demonstrated that hESC-derived striatal
progenitors, generated in vitro through an ontogeny-reca-
pitulating protocol, survive and acquire an MSN identity
upon transplantation in a rat model of HD. The grafted
cells successfully integrated in the host tissue, establishing
early structural and functional synaptic connections, with
extended projections reaching proper striatal target re-
gions. Moreover, the transplanted cells ameliorated stria-
tum-dependent sensorimotor deficits in the lesioned rats.
Despite these observations, incomplete maturation of the
graft was still evident at 2 MPT and no benefits in more
complex motor tasks could be detected, facts that are not
surprising considering the relative short observational
term of the experiments.
Because the emergence of human stem cell technology, a
few groups have set up in vitro differentiation protocols
aiming at generating striatal neurons with features resem-
bling authentic and functional MSNs. Electrophysiological
properties and marker expression are the main aspects ad-
dressed experimentally to verify the nature of the different
cell preparations. Specifically, MSNs are characterized by
the expression of markers, including the phosphoprotein
DARPP32 and the transcription factor CTIP2, whose
expression is, however, shared by other pallial glutamater-
gic neuronal subtypes (Arlotta et al., 2005). To achieve the
unequivocal identification of MSN is, therefore, necessary
to leverage their inhibitory nature by assessing simulta-(D) Percentage of cells with peak Na+ currents negligible (white), <1
(E) Percentage of cells displaying no spikes (white), abortive spikes (li
26 cells).
(F) Boxplot showing the calculated Na+ current density for each record
whereas the mean value is represented by the white triangle (n = 26
(G) Almost half population of the cells (47%) showed a fast inactivatin
(n = 26 cells).
(H) Representative trace showing spontaneous excitatory postsynap
cells), with an amplitude of 0.27 ± 0.09 mV is shown below.neously the expression of GABA or GABA producing en-
zymes (e.g., GAD65, GAD67).
Here, we have qualified our cell preparations using a sys-
tematic approach by assessing the formation of cells ex-
pressing key markers during the entire differentiation pro-
cess. We have identified mature MSNs in vitro based on the
simultaneous co-expression of the three main markers
DARPP32, CTIP2, and GABA. Because of the high level of
conservation, no valid human-specific anti-GABA anti-
body is available in the market, hampering the possibility
to perform similar analysis in vivo.
For a cell replacement therapy to be effective long-term
in HD, the cells generated in vitromust be able, upon trans-
plantation, not only to differentiate toward the expected
neuronal lineage but also to integrate in the damaged
host tissue.
Although previous preclinical works in HD models pro-
vided diverse evidence of functional activity of the gener-
ated grafts, they have often overseen aspects of connectiv-
ity by limiting the analysis to standard-resolution
colocalization of synaptic markers found in the proximity
of the transplanted cells (Ma et al., 2012) or through EM
to show that neural stem cell-derived grafts presumably
received both inhibitory and excitatory synaptic inputs
from the host without further investigating the source of
such contacts (Reidling et al., 2018). Other studies
completely neglected these types of analysis leaving the
question about transplant integration, unanswered (Adil
et al., 2018; Arber et al., 2015; Aubry et al., 2008; Mu
et al., 2014; Nicoleau et al., 2013; Wu et al., 2018).
Here, we have extensively investigated the structural syn-
aptic connections that grafts of human striatal progenitors,
obtained according to the Delli Carri protocol, were able to
establish within the host tissue. By hNCAM staining, we
showed that already 1 month after intra-striatal transplan-
tation, grafted cells were able to extend projections reach-
ing striatal target regions, such as GP and STN, with a pro-
gressive increase in hNCAM signal from 1 to 2 MPT.
Interestingly, some projections were also detected in the
SNpr, suggesting that the striato-nigral pathway is poten-
tially reforming early after transplantation.
Furthermore, by leveraging the mentioned RV-based
monosynaptic tracing approach (Grealish et al., 2015),000 pA (gray), and >1,000 pA (black) (n = 26 cells).
ght gray), single spikes (dark gray), and repetitive firing (black) (n =
ed cell. Single experimental data are indicated by solid black circles,
cells).
g outward K+ current suggesting the activation of A-type K+ current
tic potentials (sEPSPs). The relative mean synaptic event (n = 19
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Figure 7. Intra-striatal Grafts of Striatal Progenitors Alleviated
Striatum-Dependent Sensorimotor Deficits
(A) VHPT showing transplanted rats performing significantly better
compared with controls 1 MPT (see Table S4 for details on sample
size, two-way ANOVA, Group: F(1;126) = 6.18; p = 0.0142; Time:
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showed that transplanted cells are capable of establishing
structural synaptic contacts with both human cells (graft-
to-graft) and resident host tissue (host-to-graft). We
showed that transplanted cells have greater propensity to
connect with surrounding grafted cells rather than with
host tissue resident cells, while overall the connection in-
dex of starter cells significantly increases from 1 to 2 MPT
in line with a progressive increase in network formation.
Moreover, while transplanted cells were shown to be able
to make synaptic contacts with resident CB+ interneurons
already at 1 MPT, contacts with host CTIP2+ or DARPP32+
MSNs (mCherry+/HuNu/GFP) only appeared at 2 MPT.
This suggests that transplanted cells are capable of reinner-
vating intra-striatal MSN networks, but this process takes
longer compared with connection with host interneurons
(mCherry+/HuNu/GFP/CB+).
Furthermore, we have been able to detect spontaneous
excitatory postsynaptic currents in 36% of the grafted cells
at 2 MPT, supporting progressive integration of the grafted
cells, and found levels of activation that are to some extent
comparable with those found in the literature for endoge-
nous adult rodent tissues.
Interestingly, starting from 1 MPT, grafted animals
showed a partial but significant recovery in the impaired
forelimb akinesia as detected in bothVHPTand AST. Recov-
ery in hand placing upon grafting is particularly relevant,
because this deficit is known to persist indefinitely in the
presence of extensive striatal damage, such as that induced
by QA excitotoxic lesion (Woodlee et al., 2005). The hand-
placing amelioration we found is in line with former
studies on rat HD models using either rat or human whole
ganglionic eminence grafts, which could be considered as
the gold standard efficacy reference (Lelos et al., 2016,
Klein et al, 2013). Of note, human whole ganglionic
eminence grafts were shown to stabilize the impairment
in stepping, albeit with no further rescue of the phenotype
(Lelos et al., 2016). Hence, grafts of hESC-derived striatal
progenitors generated with the Delli Carri protocol appearF(4;126) = 24.41; p < 0.0001, Bonferroni multiple comparison test,
**p < 0.01).
(B) In the AST grafted rats showed a better performance at 1 and 2
MPT (**p < 0.01, *p < 0.05; two-way ANOVA, Bonferroni multiple
comparison test) compared with sham animals.
(C) The rotarod is used to assess sensorimotor coordination before
and after the lesion/graft, and the latency to fall from the rotating
rod is calculated. No differences were observed in this test between
the two groups.
(A and B) Only results related to the contralateral limb are showed
(for ipsilateral see Figure S7). Lesion: day before transplant. Data
are expressed as mean ± SEM (see also Figure S6 and Table S4 for
sample size).
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grafts in promoting recovery of spontaneous sensorimotor
responses.
These behavioral improvements nicely parallel the pro-
gressive increase in grafted cell connectivity observed by
viral tracing techniques and suggest that the newly estab-
lished circuits participate in integrating sensory and motor
information into appropriate striatal outputs. This view is
further supported by the dynamic and overall selective
outgrowth of neurites from the graft toward appropriate
target regions, which well mirrors the capacity of fiber
extension shown by rodent and human striatal primordia
grafts (Dunnett and Bjo¨rklund, 2017).
However, conversely with sensorimotor reflex responses,
we detected no significant improvement compared with
non-grafted animals over time in the rotarod test, which as-
sesses the execution of more complex motor programs and
requires the contribution of more complex motor circuits.
Additional timemay be required to attain the furthermatu-
ration of the grafted cells, and/or the expansion of the con-
nectivity to cortical and thalamic components potentially
required to support these motor tasks.
In summary, we showed that, starting from 1 MPT, stem
cell-derived human striatal progenitors grafted into HD
rats mature in vivo, with a portion of them differentiating
into MSNs, while being integrated into local circuits
composed of both transplanted and host cells. We show
extensive projections of fibers toward appropriate striatal
targets with cell differentiation and integration that support
the observed functional recovery, although experiments at
longer time points are needed to confirm the ability of the
graft to sustain long-term complex motor performances.EXPERIMENTAL PROCEDURES
Differentiation of hESCs
hESC H9 were differentiated as described previously with minor
modifications described in the Supplemental Experimental Pro-
cedures (Carri et al., 2013). For synaptic tracing experiments, 15
DIV and 18 DIV cells were transduced with a synapsin 1-driven
TVA-GP-GFP polycistronic lentiviral vector (Addgene no. 30195)
with an MOI of 10 in the presence of 4 mg/mL polybrene (Sigma-
Aldrich).
Immunocytochemistry
Cell cultures were fixed in 4% (vol/vol) paraformaldehyde for
15 min at room temperature (RT). Cells were blocked and permea-
bilized using 5% normal goat serum (Vector), with 0.1% Triton X-
100 in PBS for 1 h at RT. After washing, cells were incubated over-
night at 4C with primary antibodies (see Table S1). Next, Alexa
Fluor secondary antibodies (Thermo Fisher Scientific) were used
1:1,000 in PBS for 1 h at RT, followed by 33 washes with PBST
and 5 min incubation at RTwith 1:10,000 of DAPI (Thermo Fisher
Scientific) in PBS.High-Content qPCR
For high-content qPCR experiments, harvested cDNA was pre-
amplified using a 0.23 pool of primers prepared from the same
gene expression assays to be used for qPCR. Pre-amplification al-
lows for multiplexed sequence-specific amplification of 29 targets
plus 12 reference genes (Table S2). Gene expression experiments
were performed using the 96 3 96 qPCR DynamicArray microflui-
dic chips. Samples and probeswere loaded into 963 96 chips using
an IFC Controller HX, then transferred to a BioMark Real-Time
PCR reader following the manufacturer’s instructions (Fluidigm).Intra-striatal Transplantation of hESC-Derived
Progenitors
AthymicNIH FOXN1-RNUnudemale rats purchased fromCharles
River (200–250 g) were lesioned 8 days before transplantationwith
QA (Sigma-Aldrich) to mimic HD. The lesion was generated by
monolateral injection of 210 nmol of freshly made QA into the
right striatum using the following stereotaxic coordinates:
AP, +0.6; L, ±2.8; V, 5.0 (Ugo Basile). At 20 DIV, hESC-derived stria-
tal progenitors were detached with Accutase (STEMCELL Technol-
ogies) with 10 mM ROCK inhibitor (Sigma-Aldrich) and resus-
pended at a concentration of 50,000 cells/mL. Cells (3 3 105)
were grafted into the QA-lesioned striata using the following coor-
dinates: AP, +0.9; L, +3.1/–3.1; DV, 5.0. In sham rats, an equivalent
volume of PBS was injected in the lesioned striatum.Monosynaptic Tracing
One week before perfusion, a set of transplanted rats was injected
with EnvA-pseudotyped DGRV (a gift from Malin Parmar, Lund
University) carrying mCherry reporter to label first afferent neu-
rons (Grealish et al., 2015). For each rat a dilution of 5% of
mCherry RV, with a titer of 20–30 3 106 TU/mL, was injected
into the lesioned striatum (1 mL total volume) using the same ste-
reotaxic coordinates as for the QA lesion. All surgical procedures
were performed under deep general anesthesia obtained with 4%
isoflurane (Isoflurane-Vet 100%, Merial Italy) vaporized in O2/
N2O 30%:70%.In Vivo Imaging
PET Imaging
PET studies were performed using the high-affinity TSPO radio-
tracer [18F]VC701 to image microglia activation or macrophage
infiltration and the D2 dopamine receptor antagonist [11C]
RACLPRIDE ([11C]RAC) to image intra-striatal neurons integrity.
PET studies were performed 1 week ([18F]VC701) and 2 months
([18F]VC701 and [11C]RAC) after transplantation. [18F]VC701 and
[11C]RAC were prepared in our facility as described previously (Di
Grigoli et al., 2015; Moresco et al., 2008) and intravenously in-
jected into the rat tail vein ([18F]VC701, 9.03 ± 1.38 MBq; [11C]
RAC, 7.49 ± 2.01 MBq).
MRI
AllMRI studieswere performed on a 7T preclinical scanner (Bruker,
BioSpec 70/30 USR, Paravision 5.1). All rats were prepared for MRI
with an intravenous injection of gadobutrol (Gadovist; Bayer
Schering Pharma, Berlin) at a dose of 0.05 mmol/g of body weight.Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020 13
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All behavioral tests started 1 week before QA lesion to define the
baseline performance for each animal. All behavioral tests were
conducted blind to the rat treatment(s). The number of animals
(sham and transplanted) tested at each time point is reported in Ta-
ble S4. The following tests were performed:
Vibrissae-Evoked Hand Placing
Rats were lifted upward toward the edge of a table so that only the
vibrissae would touch the table edge (Klein et al, 2013). One fore-
paw is tested while the contralateral one is gently restrained by the
experimenter. We recorded the successful movement of the fore-
paw on the table top and assigned a score from 0 to 3, based on
the accuracy of the movement (where 0 corresponds to no move-
ment and 3 to the proper movement), after executing the trial 10
times per side. The test was performed on both the ipsi- and con-
tralesional paws.
Adjusting Steps Test
Forelimb akinesia was assessed using the adjusting steps test (Ols-
son et al., 1995). This involved restraining one forelimb and count-
ing the number of adjusting steps made by the unrestrained fore-
limb when a rat was moved sideways along a table surface for
100 cm in either a backward and forward direction with respect
to the unrestrained paw. The highest total number of touches per
trial was recorded. The data presented are the total number of ad-
justing steps made with the contralateral and ipsilateral paws.
Rotarod Test
The rats were placed on a rotating rod (Ugo Basile) and steady ac-
celeration was applied (from 4 to 40 rpm in 300 s), and their la-
tency to fall provided a measurement of their motor coordination.
The test was repeated for three times per each session and the
average latency was recorded.
Histology and Immunohistochemistry
The cryo-sections were permeabilized with 0.5% Triton X-100
(Sigma-Aldrich) and blocked with 2% donkey serum (Sigma-Al-
drich) for 1 h at RT. Next, sections were incubated overnight at
4Cwith the primary antibodies at the dilutions indicated in Table
S1. Sections were then exposed for 2 h at RT to secondary anti-
bodies conjugated with Alexa Fluor dyes (Thermo Fisher Scienti-
fic). hNCAM expression was revealed using the peroxidase tech-
nique. Immunohistochemical reactions were performed using
the avidin-biotin-peroxidase method (VECTASTAIN ABC Elite
Kit; Vector Laboratories) and revealed using 3,30-diaminobenzi-
dine (3% in Tris-HCl) as chromogen (Sigma-Aldrich).
Electrophysiological Analysis
Patch-clamp recordings, both in voltage- and current-clampmode,
were performed on submerged slices placed in a recording chamber
continuously perfused with carboxygenated artificial cerebrospi-
nal fluid at a flow rate of 0.8–1.3 mL/min. Borosilicate glass patch
pipettes were filled with the following intracellular solution: K-glu-
conate 130 mM; NaCl 4 mM; MgCl2 2 mM; HEPES 10 mM; EGTA
1 mM; creatine phosphate 5 mM; Na2ATP 2 mM; Na3GTP
0.3 mM (pH adjusted to 7.3 with KOH). For a morpho-functional
correlation, 3 mg/mL biocytin was intracellularly added through
the patch pipette and post-marked by an immunofluorescence re-
action after recordings. Electrophysiological recordings were14 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020sampled at 20 kHz and filtered at 10 kHz using Clampex 9.2 soft-
ware and a MultiClamp 700B amplifier interfaced with a personal
computer through theDigidata 1322 A/D converter board (all from
Molecular Devices, USA). In voltage clamp mode, membrane
capacitance (Cm) was evaluated by integrating the capacitive cur-
rent elicited by a 10 mV voltage step, whereas the input resis-
tance (Rin) was calculated from the same protocol when the signal
reached the steady state. Current-clamp recordings were per-
formed tomeasure the restingmembrane potential (Vr), the ability
to generate action potentials and the presence of sPSPs.
Statistical Analysis
Data were analyzed using two-tailed Mann-Whitney t test, one-
and two-way ANOVA tests, followed by Bonferroni or Dunn’s mul-
tiple comparison tests for post-hoc analyses. Using analysis of vari-
ance tests, the between-subjects factor of Group and within-sub-
jects factor of Time were used. PET and MRI data were analyzed
using the indicated Student’s t test. Results were deemed to be sta-
tistically significant when p was <0.05. *p < 0.05, **p < 0.01, ***p <
0.001. See also Table S5 for details.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.03.018.
AUTHOR CONTRIBUTIONS
D.B., R.S., S.B., G.B., R.M.M., A.B., and E.C. conceived the study
and designed the experiments. P.C., A.F., I.C., and A.L. performed
the in vitro studies. M.C. helped in producing the lentiviruses.
V.D.B. analyzed the high-content qPCR data. R.S. and R.P. per-
formed the transplantation procedures, and histological and
behavioral analysis. S.B. and V.M. performed the transplantation
procedures and the in vivo imaging analysis. P.S., F.T., C.M., and
G.B. performed the electrophysiology experiments. M.P. provided
the monosynaptic tracing constructs and suggestions on the
experimental strategy. All authors contributed to interpretation
of the data and their assembly in the manuscript. D.B., R.S.,
M.B., S.B., G.B., R.M.M., A.B., and E.C. wrote the manuscript and
was edited and proofread by all authors. G.B., R.M.M., A.B., and
E.C. secured the funding.
ACKNOWLEDGMENTS
We thank Paolo Provero for helping with statistical analysis, Pia
Rivetti Di Val Cervo for helping in the production of viral superna-
tants, Claudio Cappadona for helping with gene expression
normalization and Pasquale Simonelli for the technical support
with animal preparation and ex vivo experiments.
This work was supported by the Italian Ministry of Research and
Education (MIUR) PRIN program (GA no. 2008JKSHKN_001 and
GA. no. 2015AY9AYB) coordinated by University of Milan, E.C.,
and involving University of Torino, University of Pavia, University
ofMilano-Bicocca andCNR; by the EuropeanUnion’s fundedCon-
sortium NeurostemcellRepair (FP7 GA no. 602278) and Nsc-Recon-
struct: Novel Strategies for Cell based Neural Reconstruction (H2020,
GAno. 875758) coordinatedby E.C. and involvingA.B. (University
of Turin) and M.P. (Lund University). Finally, this work is also
Please cite this article in press as: Besusso et al., Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Senso-
rimotor Deficit in a Rat Model of Huntington Disease, Stem Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.03.018supported by the Italian Ministry of Research and Education
(MIUR) national project ‘‘Dipartimenti di Eccellenza 2018–2022’’
awarded to Department of Biosciences (University of Milan), to
Department of Neuroscience ‘‘Rita Levi Montalcini’’ (University
of Turin) and Department of Biology and Biotechnology "L. Spal-
lanzani", University of Pavia.
Received: October 21, 2019
Revised: March 17, 2020
Accepted: March 18, 2020
Published: April 16, 2020REFERENCES
Adil, M.M., Gaj, T., Rao, A.T., Kulkarni, R.U., Fuentes, C.M., Rama-
doss, G.N., Ekman, F.K., Miller, E.W., and Schaffer, D.V. (2018).
hPSC-derived striatal cells generated using a scalable 3D hydrogel
promote recovery in a Huntington disease mouse model. Stem
Cell Reports 10, 1481–1491.
Arber, C., Precious, S.V., Cambray, S., Risner-Janiczek, J.R., Kelly, C.,
Noakes, Z., Fjodorova, M., Heuer, A., Ungless, M.A., Rodriguez,
T.A., et al. (2015). ActivinAdirects striatal projectionneurondiffer-
entiation of human pluripotent stem cells. Development 142,
1375–1386.
Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R., and
Macklis, J.D. (2005). Neuronal subtype-specific genes that control
corticospinalmotor neuron development in vivo. Neuron 45, 207–
221.
Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., and Per-
rier, A.L. (2008). Striatal progenitors derived from human ES cells
mature into DARPP32 neurons in vitro and in quinolinic acid-
lesioned rats. Proc. Natl. Acad. Sci. U S A. 105, 16707–16712.
Caron, N.S., Dorsey, E.R., and Hayden, M.R. (2018). Therapeutic
approaches to Huntington disease: from the bench to the clinic.
Nat. Rev. Drug Discov. 17, 729–750.
Carri, A.D., Onorati, M., Lelos, M.J., Castiglioni, V., Faedo, A., Me-
non, R., Camnasio, S., Vuono, R., Spaiardi, P., Talpo, F., et al. (2013).
Developmentally coordinated extrinsic signals drive human
pluripotent stem cell differentiation toward authentic DARPP-
32+ medium-sized spiny neurons. Development 140, 301.
Conforti, P., Besusso, D., Bocchi, V.D., Faedo, A., Cesana, E., Ros-
setti, G., Ranzani, V., Svendsen, C.N., Thompson, L.M., Toselli,
M., et al. (2018). Faulty neuronal determination and cell polariza-
tion are reverted by modulating HD early phenotypes. Proc. Natl.
Acad. Sci.U S A. 115, E762–E771.
Di Grigoli, G., Monterisi, C., Belloli, S., Masiello, V., Politi, L.S., Val-
enti, S., Paolino, M., Anzini, M., Matarrese, M., Cappelli, A., et al.
(2015). Radiosynthesis and preliminary biological evaluation of
[18F]VC701, a radioligand for translocator Protein. Mol. Imaging
14, 7290.
Dunnett, S.B., and Bjo¨rklund, A. (2017). Chapter 1. Mechanisms
and use of neural transplants for brain repair. In Progress in Brain
Research, S.B. Dunnett and A. Bjo¨rklund, eds. (Elsevier), pp. 1–51.
Faedo, A., Laporta, A., Segnali, A., Galimberti, M., Besusso, D., Ce-
sana, E., Belloli, S., Moresco, R.M., Tropiano, M., Fuca`, E., et al.
(2017). Differentiation of human telencephalic progenitor cellsinto MSNs by inducible expression of Gsx2 and Ebf1. Proc. Natl.
Acad. Sci. U S A. 114, E1234.
Grealish, S., Heuer, A., Cardoso, T., Kirkeby, A., Jo¨nsson, M., Jo-
hansson, J., Bjo¨rklund, A., Jakobsson, J., and Parmar, M. (2015).
Monosynaptic tracing using modified rabies virus reveals early
and extensive circuit integration of human embryonic stem cell-
derived neurons. Stem Cell Reports 4, 975–983.
Klein, A., Lane, E.L., andDunnett, S.B. (2013). Brain repair in a uni-
lateral ratmodel of Huntington’s disease: new insights into impair-
ment and restoration of forelimb movement patterns (2113). Cell
Transpl. 22, 1735–1751.
Lelos, M.J., Roberton, V.H., Vinh, N.-N., Harrison, C., Eriksen, P.,
Torres, E.M., Clinch, S.P., Rosser, A.E., and Dunnett, S.B. (2016).
Direct comparison of rat- and human-derived ganglionic
eminence tissue grafts on motor function. Cell Transpl. 25, 665–
675.
Ma, L., Hu, B., Liu, Y., Vermilyea, S.C., Liu, H., Gao, L., Sun, Y.,
Zhang, X., and Zhang, S.-C. (2012). Human embryonic stem cell-
derived GABA neurons correct locomotion deficits in quinolinic
acid-lesioned mice. Cell Stem Cell 10, 455–464.
Moresco, R.M., Lavazza, T., Belloli, S., Lecchi, M., Pezzola, A.,
Todde, S., Matarrese, M., Carpinelli, A., Turolla, E., Zimarino, V.,
et al. (2008). Quinolinic acid induced neurodegeneration in the
striatum: a combined in vivo and in vitro analysis of receptor
changes and microglia activation. Eur. J. Nucl. Med. Mol. Imaging
35, 704–715.
Mu, S.,Wang, J., Zhou, G., Peng,W., He, Z., Zhao, Z., Mo, C., Qu, J.,
and Zhang, J. (2014). Transplantation of induced pluripotent stem
cells improves functional recovery in Huntington’s disease rat
model. PLoS One 9, e101185.
Nicoleau, C., Varela, C., Bonnefond, C., Maury, Y., Bugi, A., Aubry,
L., Viegas, P., Bourgois-Rocha, F., Peschanski, M., and Perrier, A.L.
(2013). Embryonic stem cells neural differentiation qualifies the
role of Wnt/b-Catenin signals in human telencephalic specifica-
tion and regionalization: human ESC telencephalic differentia-
tion. Stem Cells 31, 1763–1774.
Olsson, M., Nikkhah, G., Bentlage, C., and Bjorklund, A. (1995).
Forelimb akinesia in the rat Parkinson model: differential effects
of dopamine agonists and nigral transplants as assessed by a new
stepping test. J. Neurosci. 15, 3863.
Pundt, L.L., Kondoh, T., Conrad, J.A., and Low,W.C. (1996). Trans-
plantation of human fetal striatum into a rodent model of Hun-
tington’s disease ameliorates locomotor deficits. Neurosci. Res.
24, 415–420.
Reidling, J.C., Relan˜o-Gine´s, A., Holley, S.M., Ochaba, J., Moore,
C., Fury, B., Lau, A., Tran, A.H., Yeung, S., Salamati, D., et al.
(2018). Human neural stem cell transplantation rescues functional
deficits in R6/2 andQ140Huntington’s diseasemice. StemCell Re-
ports 10, 58–72.
Tabrizi, S.J., Ghosh, R., and Leavitt, B.R. (2019a). Huntingtin
lowering strategies for disease modification in Huntington’s dis-
ease. Neuron 101, 801–819.
Tabrizi, S.J., Leavitt, B.R., Landwehrmeyer, G.B., Wild, E.J., Saft, C.,
Barker, R.A., Blair, N.F., Craufurd, D., Priller, J., Rickards, H., et al.Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020 15
Please cite this article in press as: Besusso et al., Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Senso-
rimotor Deficit in a Rat Model of Huntington Disease, Stem Cell Reports (2020), https://doi.org/10.1016/j.stemcr.2020.03.018(2019b). Targeting Huntingtin expression in patients with Hun-
tington’s disease. N. Engl. J. Med. 381, 1398.
Vonsattel, J.P.G., Keller, C., Amaya, Pilar, and del, M. (2008).
Neuropathology of Huntington’s disease. In Handbook of Clinical
Neurology (Elsevier), pp. 599–618.
Wictorin, K. (1992). Anatomy and connectivity of intrastriatal
striatal transplants. Prog. Neurobiol. 38, 611–639.
Woodlee, M.T., Asseo-Garcı´a, A.M., Zhao, X., Liu, S.J., Jones, T.A.,
and Schallert, T. (2005). Testing forelimb placing "across the16 Stem Cell Reports j Vol. 14 j 1–16 j May 12, 2020midline" reveals distinct, lesion-dependent patterns of recovery
in rats. Exp. Neurol. 2, 310–317.
Wu, M., Zhang, D., Bi, C., Mi, T., Zhu, W., Xia, L., Teng, Z., Hu, B.,
and Wu, Y. (2018). A chemical recipe for generation of clinical-
grade striatal neurons from hESCs. Stem Cell Reports 11, 635–650.
Zeitler, B., Froelich, S., Marlen, K., Shivak, D.A., Yu, Q., Li, D., Pearl,
J.R., Miller, J.C., Zhang, L., Paschon, D.E., et al. (2019). Allele-selec-
tive transcriptional repression of mutant HTT for the treatment of
Huntington’s disease. Nat. Med. 25, 1131–1142.
